Gingival Enlargements

Gingival enlargements (GEs) are a commonly observed clinical entity in dentistry. The etiology maybe local, systemic, or a combination. Having a good diagnostic certainty of the type of GE helps the clinician to not only manage the entity locally but facilitates a thorough workup of the systemic factors. This article offers an in-depth look at the diagnosis and subsequent clinical management strategies for various forms of GE. It emphasizes the importance of accurately recognizing the diverse clinical presentations of GE, guided by its etiopathogenesis, clinical features, and other investigations. Achieving an accurate diagnosis is crucial for effective management.

Key points

  • It is essential for clinicians to possess an in-depth awareness of the various forms of gingival enlargement (GE), given their significant impact on prognosis and patient outcomes.

  • Dentists must acknowledge and address both the oral hygiene and psychological implications associated with GE by initiating timely and effective management strategies.

  • Managing drug-influenced GE and GE secondary to systemic factors often requires a multidisciplinary approach. Therefore, clinicians should be cognizant of the importance of prompt referrals to physicians when indicated.

Abbreviations

DIGE drug-influenced gingival enlargement
GE gingival enlargement

Introduction

The term gingival enlargement (GE) refers to an increase in the gingival size. The condition is multifactorial. The various etiologic factors include genetics, medications, dental plaque, and systemic diseases, among others. , There appears to be considerable changes, and many times some level of confusion in the literature regarding the terminology. Terms such as gingival hyperplasia, gingival hypertrophy, drug-induced gingival hyperplasia, and other previous synonyms have been largely replaced in the literature by the term “GE”. Throughout this article, we have used the term GE to reflect the most current dental literature. In this article, we review the etiology, classification, pathophysiology, clinical features, differential diagnosis, management, and other factors as related to GE.

Terminology and classification

A universally acceptable succinct classification of GE is lacking in the existing literature. The lack of consensus in the related terminology and the various definitions used over the past several decades may have contributed to this shortcoming in the literature. It must be noted, however, that relative consensus can be found in the periodontal literature, especially the periodontal disease classifications of 1999 and 2017 by the American Academy of Periodontology. , To add to this apparent confusion, various textbooks recommended globally for dental undergraduate education, also show varying and dissimilar terminologies. Many times, the terms GE and gingival overgrowth also seem to be interchangeably used in these standard dental/periodontal textbooks. ,,, There is a current necessity for a universally acceptable classification of GE that can be a consensus among various dental specialties and related professional organizations. One of the most prevalent forms of GE is often associated with gingivitis-induced inflammation, more commonly seen in adolescents undergoing orthodontic treatment. ,

The second and the more diagnostically challenging form of the GE is drug-influenced gingival enlargement (DIGE). The systemic use of, primarily, 3 classes of drugs—anticonvulsants, calcium channel blockers, and immunosuppressants, have been identified in the causation of DIGE. , GE has also been associated with certain genetic conditions, systemic conditions, hormonal changes, or even neoplastic conditions. , A GE condition that cannot be attributed to any of the aforementioned causes, can be classified under idiopathic GE. Throughout the literature on classification of GE, there appears to be a significant lack of consensus between and among various professional organizations and specialty academies in dentistry.

Etiology, pathophysiology, and clinical features of common gingival enlargement

The distinct pathologic characteristics of all GEs, regardless of their cause, necessitate careful attention during diagnostic and therapeutic procedures, as well as during the maintenance. Recurrence is a significant concern, especially when systemic conditions are involved, making it vital to determine the etiology and any contributing factors. The more common GE entities are summarized in Table 1 .

Table 1

Etiology, pathophysiology, and clinical features of common gingival enlargement

Category Etiology Pathogenesis Clinical Features
Inflammatory gingival enlargement ,
  • Prolonged exposure to dental plaque.

  • Poor oral hygiene.

  • Local irritants (eg, calculus, faulty restorations).

  • Edema and inflammatory cell infiltration in the connective tissue.

  • Increased vascularity.

  • Potential epithelial proliferation.

  • Reddish, bluish red and edematous.

  • Bleeding upon probing.

  • Soft, spongy texture, loss of stippling.

  • May be localized or generalized.

Drug-influenced gingival enlargement ,
  • Certain medications: (most commonly presented)

    • a.

      Phenytoin (anticonvulsant).

    • b.

      Cyclosporine (immunosuppressant).

    • c.

      Nifedipine (calcium channel blocker).

  • Immune mediation.

  • Increased connective tissue matrix and fibroblasts production.

  • Epithelial hyperplasia.

  • Increased production of collagen.

  • Firm, pink gingiva.

  • Often begins in the interdental papillae.

  • Can become extensive, covering portions of the teeth.

Systemic conditions ,,
  • Hormonal changes (eg, pregnancy, puberty).

  • Leukemia.

  • Granulomatous diseases (eg, sarcoidosis).

  • Genetic conditions.

  • Varies depending on the underlying condition.

  • May involve increased vascularity, cellular infiltration, or connective tissue proliferation.

  • Varies depending on the underlying condition. May be generalized.

  • Hormonal changes result in increased inflammatory response to local irritants.

  • Leukemia can produce very dramatic enlargement.

Hereditary gingival fibromatosis ,,
  • Genetic predisposition.

  • Autosomal dominant.

  • More sub-epithelial fibroblast proliferation and greater collagen and fibronectin synthesis.

  • Reduction in the matrix metalloproteinases that degrade collagen.

  • Slow, progressive enlargement.

  • Firm, pale pink gingiva, with marked stippling. Can cover significant portions of the teeth.

Etiology, pathophysiology, and clinical features of uncommon gingival enlargement

Orthodontic appliances, fixed dental prostheses, and removable dentures each contribute to GE through unique mechanisms. These factors initiate a cascade of inflammatory and fibrotic changes within the gingival tissues, ultimately leading to distinct clinical presentation. The etiology, pathophysiology, and clinical features of these entities are summarized in Table 2 .

Table 2

Etiology, pathophysiology, and clinical features of uncommon gingival enlargement

Category Etiology Pathogenesis Clinical Features
Orthodontic bracket/material related GE ,,,,,,
  • Plaque retention.

  • Difficulty maintaining oral hygiene.

  • Nickel release.

  • Mechanical irritation.

  • Excess resin or cement.

  • Inflammatory mediators.

  • Increased vascular permeability.

  • Connective tissue and epithelial hyperplasia.

  • Fibrotic gingiva.

  • Anterior labial gingiva.

  • Interproximal papilla.

  • Erythema.

  • Bleeds on probing.

GE related to fixed dental prosthesis ,,,
  • Plaque.

  • Mechanical irritation (over-contoured crowns, ill-fitting crowns).

  • Food impaction.

  • Violation of biological width/supracrestal tissue attachment.

  • Inflammation.

  • Fibroblast proliferation.

  • Extracellular matrix accumulation.

  • Interdental papillae and marginal gingiva adjacent to crowns.

  • Fibrotic or edematous.

  • Bleeding on probing.

  • Pocket formation.

  • Bone loss or implant failure.

GE related to removable prosthesis ,,,
  • Mechanical irritation from ill-fitting dentures.

  • Continuous denture wear.

  • Poor oral and denture hygiene.

  • Chronic trauma.

  • Fibrous connective tissue.

  • Epulis fissuratum:

  • Vestibular mucosa. Maxillary labial vestibule.

  • Hyperplastic tissue.

  • Asymptomatic; may become painful.

  • Denture stomatitis.

Peripheral giant cell granuloma ,,,,,,
  • Local irritations or trauma.

  • Systemic conditions such as hyperparathyroidism.

  • Hormonal factors.

  • None encapsulated.

  • Multinucleated giant cells.

  • Red to purplish/blue modular mass.

  • Gingiva alveolar mucosa; mandible; anterior to the molars.

GE can be classified based on various factors, including but not limited to etiology, tissue appearance, etiopathogenesis, location, and distribution among others. A brief summary of these classifications is depicted in Fig. 1 . ,

Fig. 1

Classification of GE.

Diagnostic approaches

Thorough patient history and clinical examination are paramount. A photographic documentation, by means of pictures or intra-oral scans, may be beneficial for both patient education and prognosis assessment. Appropriate imaging followed by succinct laboratory/blood investigations should be ordered by the treating clinician. Tissue biopsy accompanied by histopathology may be warranted in certain cases. The most probable differential diagnoses, finally culminating in diagnosis proper, is instrumental in optimal management of GE. A diagnostic paradigm and a suggested sequential clinical approach are summarized in Fig. 2 .

Fig. 2

Sequential diagnostic and management paradigm for GE.

Management strategies

Management strategies for GE primarily are based on etiology.

  • 1.

    Non-surgical management:

    • Oral hygiene instructions

    • Scaling and root planing

    • Drug substitution (in drug-influenced cases)

    • Management of underlying systemic conditions

  • 2.

    Surgical management:

    • Gingivectomy/gingivoplasty

    • Flap surgery

    • Mucogingival/periodontal plastic surgery

    • Laser gingivectomy

    • Other modalities such as photobiomodulation therapy, host modulation therapy, and novel drug delivery systems.

Management of plaque-induced GE is well documented in the literature, the pillar stones being meticulous plaque control and oral hygiene maintenance. For the management of DIGE, keeping plaque in check is essential, along with potential drug substitution following discussion with a physician. ,

Nifedipine, a known drug for GE, can be replaced by alternatives such as benidipine, nicardipine, or isradipine, which have not demonstrated an association with this condition. , In cases where complete resolution is not achieved, surgical intervention may become necessary.

In orthodontic-related GE, key interventions include reinforcing oral hygiene through the use of interdental brushes and antimicrobial mouth rinses, performing professional plaque removal, and modifying appliances to reduce mechanical irritation. , For patients with nickel sensitivity, switching to non-metallic alternatives is recommended. , When GE is linked to fixed prostheses, treatment focuses on correcting design flaws such as over-contouring or poor fit, maintaining optimal plaque control through regular dental visits, addressing any associated periodontal issues, and surgically excising fibrotic tissue when indicated. ,, For removable prosthesis-induced GE, management includes adjusting or replacing ill-fitting dentures, advising patients to remove prostheses overnight to facilitate tissue healing, improving hygiene with antifungal agents, if needed, and performing surgical excision of hyperplastic tissue in severe cases. ,,, A flow chart representing a sequential diagnostic and management paradigm is depicted in Fig. 2 .

If GE persists and/or recurs, surgical management may be considered. The various surgical modalities, along with their indications, advantages, and limitations have been listed in Table 3 .

Table 3

Surgical techniques for gingival enlargement: indications, advantages, and limitations

Technique Indications Advantages Limitations
Gingivectomy , Suprabony enlargement, no bone loss.
  • Straightforward removal of excess tissue.

  • Improves access and gingival contour.

  • Cost-effective.

  • Limited pocket reduction in deep cases.

  • May not preserve keratinized tissue.

  • Potential for recurrence.

Gingivoplasty Contour sculpting, esthetic finishing.
  • Refines gingival shape for esthetics.

  • Easily combined with gingivectomy.

  • Limited impact on pocket depth.

Flap surgery , Pocket with bone loss/attachment loss.
  • Deep pocket access and root debridement.

  • Enables regenerative procedure.

  • More invasive, longer healing.

  • May result in recession.

Mucogingival/periodontal plastic surgery , Recession, keratinized tissue deficiency, esthetics.
  • Corrects defects and increases attached gingiva.

  • Technically demanding.

  • Often warrants secondary/donor site involvement

Laser gingivectomy , Need for hemostasis, comfort, esthetics.
  • Precision cutting with hemostasis.

  • Expensive

  • Additional training needed.

  • Potential thermal damage.

Dual flap internal gingivectomy DIGE and periodontitis
  • Preserve keratinized tissue.

  • Address both soft and hard tissue safely.

  • Complex technique.

  • Limited to severe cases.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free dental videos. Join our Telegram channel

Jul 12, 2026 | Posted by in Oral and Maxillofacial Surgery | Comments Off on Gingival Enlargements

VIDEdental - Online dental courses

Get VIDEdental app for watching clinical videos